Edition:
India

Alexion Pharmaceuticals Inc (ALXN.OQ)

ALXN.OQ on NASDAQ Stock Exchange Global Select Market

103.28USD
1:30am IST
Change (% chg)

$-0.62 (-0.60%)
Prev Close
$103.90
Open
$103.60
Day's High
$104.14
Day's Low
$102.34
Volume
816,081
Avg. Vol
873,534
52-wk High
$125.51
52-wk Low
$73.54

Select another date:

Thu, Jul 2 2020

Alexion pays $21 million resolving charges of breaking U.S. foreign corruption law: SEC

WASHINGTON Alexion Pharmaceuticals has agreed to pay $21 million to resolve U.S. charges that it violated a major anti-corruption law when two of its subsidiaries paid Turkish and Russian officials for favorable treatment of its Soliris drug, the top securities regulator said on Thursday.

Alexion pays $21 mln resolving charges of breaking U.S. foreign corruption law -SEC

WASHINGTON, July 2 Alexion Pharmaceuticals has agreed to pay $21 million to resolve U.S. charges that it violated a major anti-corruption law when two of its subsidiaries paid Turkish and Russian officials for favorable treatment of its Soliris drug, the top securities regulator said on Thursday.

BRIEF-Alexion Pharmaceuticals Says ULTOMIRIS Gets Marketing Authorization From European Commission

* ALEXION PHARMACEUTICALS-ULTOMIRIS GETS MARKETING AUTHORIZATION FROM EUROPEAN COMMISSION FOR ADULTS,CHILDREN WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME Source text for Eikon: Further company coverage:

BRIEF-Alexion Announces Phase 3 Study Of Weekly Subcutaneous Ultomiris Met Primary Endpoint

* ALEXION ANNOUNCES PHASE 3 STUDY OF WEEKLY SUBCUTANEOUS ULTOMIRIS® (RAVULIZUMAB-CWVZ) MET PRIMARY ENDPOINT Source text for Eikon: Further company coverage:

Deals of the day-Mergers and acquisitions

May 12 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

Activist investor Elliott pushes Alexion Pharma to sell itself

Hedge fund Elliott Management on Tuesday publicly called on Alexion Pharmaceuticals Inc to sell itself, arguing that management's steps, including recent plans to acquire a smaller company, were leading in the wrong direction.

Activist investor Elliott pushes Alexion Pharma to sell itself

Hedge fund Elliott Management on Tuesday publicly called on Alexion Pharmaceuticals Inc to sell itself, arguing that management's steps, including recent plans to acquire a smaller company, were leading in the wrong direction.

UPDATE 2-Activist investor Elliott pushes Alexion Pharma to sell itself

May 12 Hedge fund Elliott Management on Tuesday publicly called on Alexion Pharmaceuticals Inc to sell itself, arguing that management's steps, including recent plans to acquire a smaller company, were leading in the wrong direction.

Elliott again pushes Alexion Pharma to explore a sale

May 12 Activist investor Elliott Management on Tuesday revived its call for a sale of Alexion Pharmaceuticals Inc, months after the company rejected the hedge fund's earlier demand.

BRIEF-Elliott Advisors Sends Letter To Alexion Pharmaceuticals

* ELLIOTT ADVISORS, IN LETTER TO ALEXION, SAYS BEST APPROACH FOR ALEXION IS IMMEDIATE EXPLORATION OF A SALE

Select another date: